Ertl HCJ - Search Results

1

Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial.

Jenkin D, Ritchie AJ, Aboagye J, Fedosyuk S, Thorley L, Provstgaad-Morys S, Sanders H, Bellamy D, Makinson R, Xiang ZQ, Bolam E, Tarrant R, Ramos Lopez F, Platt A, Poulton I, Green C, Ertl HCJ, Ewer KJ, Douglas AD. Jenkin D, et al. Among authors: ertl hcj. Lancet Microbe. 2022 Sep;3(9):e663-e671. doi: 10.1016/S2666-5247(22)00126-4. Epub 2022 Jul 27. Lancet Microbe. 2022. PMID: 35907430 Free PMC article. Clinical Trial.

2

Transfer of maternal antibodies results in inhibition of specific immune responses in the offspring.

Xiang ZQ, Ertl HC. Xiang ZQ, et al. Virus Res. 1992 Aug;24(3):297-314. doi: 10.1016/0168-1702(92)90125-s. Virus Res. 1992. PMID: 1413989

3

Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.

Schumacher CL, Dietzschold B, Ertl HC, Niu HS, Rupprecht CE, Koprowski H. Schumacher CL, et al. J Clin Invest. 1989 Sep;84(3):971-5. doi: 10.1172/JCI114260. J Clin Invest. 1989. PMID: 2760222 Free PMC article.

4

Comparison of the effects of amino acid substitutions and beta-N- vs. alpha-O-glycosylation on the T-cell stimulatory activity and conformation of an epitope on the rabies virus glycoprotein.

Otvos L Jr, Krivulka GR, Urge L, Szendrei GI, Nagy L, Xiang ZQ, Ertl HC. Otvos L Jr, et al. Biochim Biophys Acta. 1995 May 29;1267(1):55-64. doi: 10.1016/0167-4889(95)00030-v. Biochim Biophys Acta. 1995. PMID: 7540044 Free article.

5

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.

Yang Y, Xiang Z, Ertl HC, Wilson JM. Yang Y, et al. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7257-61. doi: 10.1073/pnas.92.16.7257. Proc Natl Acad Sci U S A. 1995. PMID: 7638177 Free PMC article.

6

Immune responses to nucleic acid vaccines to rabies virus.

Xiang ZQ, Spitalnik SL, Cheng J, Erikson J, Wojczyk B, Ertl HC. Xiang ZQ, et al. Virology. 1995 Jun 1;209(2):569-79. doi: 10.1006/viro.1995.1289. Virology. 1995. PMID: 7778289 Free article.

7

Stable secretion of a soluble, oligomeric form of rabies virus glycoprotein: influence of N-glycan processing on secretion.

Wojczyk B, Shakin-Eshleman SH, Doms RW, Xiang ZQ, Ertl HC, Wunner WH, Spitalnik SL. Wojczyk B, et al. Biochemistry. 1995 Feb 28;34(8):2599-609. doi: 10.1021/bi00008a026. Biochemistry. 1995. PMID: 7873541

8

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines.

Xiang Z, Ertl HC. Xiang Z, et al. Immunity. 1995 Feb;2(2):129-35. doi: 10.1016/s1074-7613(95)80001-8. Immunity. 1995. PMID: 7895169 Free article.

9

A simple method to test the ability of individual viral proteins to induce immune responses.

Xiang ZQ, Ertl HC. Xiang ZQ, et al. J Virol Methods. 1994 Apr;47(1-2):103-16. doi: 10.1016/0166-0934(94)90070-1. J Virol Methods. 1994. PMID: 8051219

10

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Xiang ZQ, et al. Virology. 1994 Feb 15;199(1):132-40. doi: 10.1006/viro.1994.1105. Virology. 1994. PMID: 8116236 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters